| ADAM19 | |
|---|---|
| Protein Name | A Disintegrin and Metalloproteinase 19 |
| Gene | [ADAM19](/genes/adam19) |
| UniProt ID | [Q9JHF4](https://www.uniprot.org/uniprot/Q9JHF4) |
| Protein Family | ADAM family, metalloproteases |
| Molecular Weight | ~105 kDa (pro-form) |
| Expression | Heart, brain, skeletal muscle, testis |
| Function | Proteolysis, cell adhesion, signaling |
ADAM19 (A Disintegrin and Metalloproteinase 19) is a member of the ADAM (A Disintegrin and Metalloproteinase) family of transmembrane proteins. ADAMs are multifunctional proteins involved in proteolysis, cell adhesion, and cell signaling. ADAM19 is expressed in various tissues including the heart, brain, and skeletal muscle, where it participates in development, tissue remodeling, and disease processes. Recent research suggests ADAM19 may play roles in Alzheimer's disease, Parkinson's disease, and other neurological conditions [1].
ADAM19 contains multiple functional domains:
ADAM19 exhibits protease activity:
ADAM19 also mediates:
In the brain, ADAM19 is expressed in:
During neural development, ADAM19:
In Alzheimer's disease, ADAM19 may contribute to:
ADAMs are involved in amyloid precursor protein (APP) processing:
ADAM19 in inflammatory responses:
In Parkinson's disease, ADAM19 roles include:
ADAM19 has been implicated in:
Broad-spectrum ADAM inhibitors have been developed:
More targeted approaches:
ADAM19 is a multifunctional ADAM family protein with protease, adhesion, and signaling activities. In the nervous system, ADAM19 participates in development, synaptic function, and inflammatory responses. Dysregulation of ADAM19 may contribute to neurodegenerative diseases including Alzheimer's and Parkinson's disease through effects on protein processing, neuroinflammation, and neuronal survival. Further research into ADAM19 biology may reveal therapeutic opportunities for these conditions.